Biotech startups that raised Series A in Belgium
Updated 16 Nov 2026
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| Amyl Therapeutics | Liège | Series A | $9.6M | 2026-09-01 |
| Bioxodes | Marche-en-famenne | Series A | $6.4M | 2025-12-10 |
| Augustine Therapeutics | Leuven | Series A | $83.9M | 2025-03-24 |
| EsoBiotec | Mont-saint-guibert | Series A | $2.2M | 2023-12-12 |
4 rows of the CSV in 5 of its 18 columns.
- The 25 biotech startups in Belgium whose last round is Series A have raised $513.7M in total.
- 5 of them closed their most recent round in the last 12 months, $151.0M combined.
- The largest of those rounds is Coultreon Biopharma's $125.0M Series A, dated April 2026.
- The most recent is 4Tissue's $7.9M Series A on 20 October 2026.
- Sambrinvest is an investor in 2 of them, more than any other fund.
- Health care is the most common other sector, with 22 companies (88%).
- 36% were founded in 2020 or later; the median founding year is 2018.
- The most common team size is 11 to 50 employees (76% of companies with a recorded size).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
5 of 25| Company | What they do | Sector | City | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| Amyl Therapeutics | Amyl Therapeutics is a preclinical biotechnology company developing immunotherapy for neurodegenerative diseases. | Biotech | Liège | Series A | $9.6M | 2026-09-01 | $44.0M | Meusinvest (Noshaq), Sambrinvest, Mérieux Equity Partners +1 | 1 to 10 | 2020 |
| Bioxodes | Bioxodes develops high value products derived from natural sources. | Biotech | Marche-en-famenne | Series A | $6.4M | 2025-12-10 | $25.6M | European Commission | 11 to 50 | 2013 |
| Augustine Therapeutics | Augustine Therapeutics discovers and develops medicines for neuromuscular and neurodegenerative diseases. | Biotech | Leuven | Series A | $83.9M | 2025-03-24 | $106.8M | PMV, V-Bio Ventures, VIB | 11 to 50 | 2019 |
| EsoBiotec | EsoBiotec is a Belgian biotechnology company that discovers novel cancer therapies. | Biotech | Mont-saint-guibert | Series A | $2.2M | 2023-12-12 | Thuja Capital, Sambrinvest, S.R.I.W. +2 | 11 to 50 | 2020 | |
| ONTOFORCE | ONTOFORCE is a Belgian semantic technology company that provides solutions for improving information management. | Biotech | Ghent | Series A | $5.3M | 2018-01-25 | PMV, Limburgse Reconversie Maatschappij, Korys | 11 to 50 | 2011 |
Table 1. Biotech startups that raised Series A in Belgium: the 5 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 25.
Largest rounds
Last 12 months| # | Company | What they do | Sector | City | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Amyl Therapeutics | Amyl Therapeutics is a preclinical biotechnology company developing immunotherapy for neurodegenerative diseases. | Biotech | Liège | Series A | $9.6M | 2026-09-01 | $44.0M | Meusinvest (Noshaq), Sambrinvest, Mérieux Equity Partners +1 | 1 to 10 | 2020 |
| 2 | Bioxodes | Bioxodes develops high value products derived from natural sources. | Biotech | Marche-en-famenne | Series A | $6.4M | 2025-12-10 | $25.6M | European Commission | 11 to 50 | 2013 |
Table 2. Biotech startups that raised Series A in Belgium: the 2 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | Sambrinvest | Venture capital firm | Gosselies, Belgium | 2 | 8% | 1 | Amyl Therapeutics |
| 2 | PMV | Government investment office | Brussels, Belgium | 2 | 8% | ||
| 3 | Meusinvest (Noshaq) | Venture capital firm | Liège, Belgium | 1 | 4% | 1 | Amyl Therapeutics |
| 4 | Mérieux Equity Partners | Private equity firm | Lyon, France | 1 | 4% | 1 | Amyl Therapeutics |
| 5 | Smedvig | Family office | Stavanger, Norway | 1 | 4% | 1 | Amyl Therapeutics |
| 6 | European Commission | Government investment office | Brussels, Belgium | 1 | 4% | 1 | Bioxodes |
| 7 | VIB | Venture capital firm | Ghent, Belgium | 1 | 4% | ||
| 8 | V-Bio Ventures | Venture capital firm | Ghent, Belgium | 1 | 4% | ||
| 9 | S.R.I.W. | Government investment office | Liège, Belgium | 1 | 4% | ||
| 10 | Thuja Capital | Startup accelerator | Utrecht, The Netherlands | 1 | 4% | ||
| 11 | UCB Ventures | Corporate venture arm | Brussels, Belgium | 1 | 4% | ||
| 12 | Invivo Capital Partners | Venture capital firm | Barcelona, Spain | 1 | 4% | ||
| 13 | Korys | Family office | Halle, Belgium | 1 | 4% | ||
| 14 | Limburgse Reconversie Maatschappij | Private equity firm | Hasselt, Belgium | 1 | 4% |
Table 3. Biotech startups that raised Series A in Belgium: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
| Sectors | Companies | Share | Total raised |
|---|---|---|---|
| Health care | 22 | 88% | $497.7M |
| Software | 2 | 8% | $11.7M |
| Artificial intelligence | 1 | 4% | $11.7M |
Table 4. Biotech startups that raised Series A in Belgium by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
| Funding stage | Companies | Share | Median last round |
|---|---|---|---|
| Series A | 25 | 100% | $9.2M |
Table 5. Biotech startups that raised Series A in Belgium by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Cities
| Cities | Companies | Share |
|---|---|---|
| Ghent | 3 | 12% |
| Liège | 3 | 12% |
| Leuven | 2 | 8% |
| Louvain-la-neuve | 2 | 8% |
| Wondelgem | 1 | 4% |
| Heverlee | 1 | 4% |
| Marche-en-famenne | 1 | 4% |
| Genk | 1 | 4% |
| Aye | 1 | 4% |
| Mont-saint-guibert | 1 | 4% |
| Charleroi | 1 | 4% |
| Geel | 1 | 4% |
Table 6. Biotech startups that raised Series A in Belgium by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| October 2026 | 1 | 20% | $7.9M |
| September 2026 | 2 | 40% | $11.7M |
| April 2026 | 1 | 20% | $125.0M |
| December 2025 | 1 | 20% | $6.4M |
Table 7. Biotech startups that raised Series A in Belgium: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 4 | 16% | $144.6M |
| 2025 | 3 | 12% | $102.1M |
| 2024 | 2 | 8% | $73.2M |
| 2023 | 4 | 16% | $60.3M |
| 2021 | 3 | 12% | $56.7M |
| 2020 | 1 | 4% | $7.0M |
Table 8. Biotech startups that raised Series A in Belgium by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2023 or later | 2 | 8% |
| 2020 to 2022 | 7 | 28% |
| 2015 to 2019 | 11 | 44% |
| 2010 to 2014 | 4 | 16% |
| Before 2010 | 1 | 4% |
Table 9. Biotech startups that raised Series A in Belgium by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 6 | 24% |
| 11 to 50 | 19 | 76% |
Table 10. Biotech startups that raised Series A in Belgium by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when Biotech is one of its sectors and its most recent funding round is Series A and its headquarters is in Belgium. On 16 November 2026 that is 25 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 5 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 25 rows: 1 have no round amount, 0 no city and 6 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many biotech startups in Belgium whose last round is Series A are on the list?
- 25, in the file dated 16 November 2026. 5 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 25 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.